Association of serum phosphorus variability with coronary artery calcification among hemodialysis patients

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Wang, Mengjing ^a   Li, Haiming ^a   You, Li ^a   Yu, Xiaoling ^a   Zhang, Min ^a   Zhu, Ruijiang ^b   Hao, Chuanming ^a   Zhang, Zhijie ^a   Chen, Jing ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CHINA; CHINESE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; AGED; BLOOD; CALCINOSIS; CORONARY ARTERY DISEASE; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CALCINOSIS; CALCIUM; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; RENAL DIALYSIS; RISK FACTORS;

EID: 84899694951     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093360     Document Type: Article

References (80)

1. Barreto DV, Barreto FC, Carvalho AB, Cuppari L, Cendoroglo M, et al. (2005) Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int 67:1576-1582. (Pubitemid 40463138)
2. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, et al. (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695-701. (Pubitemid 34158168)
3. Pencak P, Czerwienska B, Ficek R, Wyskida K, Kujawa-Szewieczek A, et al. (2013) Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients. BMC Nephrol 14:10.
4. Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, et al. (2003) Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 107:2571-2576. (Pubitemid 36628938)
5. Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, et al. (2000) Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 86:495-498.
6. Haydar AA, Hujairi NM, Covic AA, Pereira D, Rubens M, et al. (2004) Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 19:2307-2312. (Pubitemid 39214126)
7. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. (2005) Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 46:158-165. (Pubitemid 40905145)
8. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, et al. (2004) Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 65:2380-2389. (Pubitemid 38670024)
9. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, et al. (2009) Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 302:1782-1789.
10. Foley RN, Parfrey PS, Sarnak MJ. (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-119. (Pubitemid 28527268)
11. Taki K, Takayama F, Tsuruta Y, Niwa T. (2006) Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney Int 70:218-224. (Pubitemid 44000142)
12. Ohtake T, Ishioka K, Honda K, Oka M, Maesato K, et al. (2010) Impact of coronary artery calcification in hemodialysis patients: Risk factors and associations with prognosis. Hemodial Int 14:218-225.
13. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, et al. (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483. (Pubitemid 30318271)
14. Ozkok A, Caliskan Y, Sakaci T, Erten G, Karahan G, et al. (2012) Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. Clin J Am Soc Nephrol 7:965-973.
15. Barreto DV, Barreto Fde C, Carvalho AB, Cuppari L, Draibe SA, et al. (2008) Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. Am J Kidney Dis 52:1139-1150.
16. Khan AM, Chirinos JA, Litt H, Yang W, Rosas SE. (2012) FGF-23 and the progression of coronary arterial calcification in patients new to dialysis. Clin J Am Soc Nephrol 7:2017-2022.
17. McCullough PA, Sandberg KR, Dumler F, Yanez JE. (2004) Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol 17:205-215. (Pubitemid 38779772)
18. Hujairi NM, Afzali B, Goldsmith DJ. (2004) Cardiac calcification in renal patients: what we do and don't know. Am J Kidney Dis 43:234-243. (Pubitemid 38146321)
19. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607-617.
20. Jung HH, Kim SW, Han H. (2006) Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 21:1915-1920. (Pubitemid 43985720)
21. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, et al. (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394-401. (Pubitemid 26075849)
22. Shantouf R, Kovesdy CP, Kim Y, Ahmadi N, Luna A, et al. (2009) Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol 4:1106-1114.
23. Portale AA, Halloran BP, Morris RC, Jr. (1987) Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest 80:1147-1154. (Pubitemid 18075654)
24. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. (2011) Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 109:697-711.
25. Wang M, You L, Li H, Lin Y, Zhang Z, et al. (2013) Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function. Clin J Am Soc Nephrol 8:116-125.
26. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, et al. (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16:520-528. (Pubitemid 41725150)
27. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, et al. (2010) Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375:895-905.
28. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr., et al. (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827-832. (Pubitemid 20101575)
29. National Kidney Foundation. (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1-201.
30. Daugirdas JT. (1993) Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 4:1205-1213.
31. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, et al. (2004) Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 15:1061-1070. (Pubitemid 38375326)
32. Watson PE, Watson ID, Batt RD. (1980) Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 33:27-39. (Pubitemid 10141676)
33. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, et al. (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429-435. (Pubitemid 38787398)
34. Rumberger JA, Brundage BH, Rader DJ, Kondos G. (1999) Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 74:243-252. (Pubitemid 29135631)
35. Foley RN, Parfrey PS, Sarnak MJ. (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9:S16-23.
36. Bhan I, Thadhani R. (2009) Vascular calcification and ESRD: a hard target. Clin J Am Soc Nephrol 4 Suppl 1:S102-105.
37. Nitta K, Akiba T, Uchida K, Otsubo S, Otsubo Y, et al. (2004) Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res 27:47-52. (Pubitemid 38208421)
38. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113:S1-130.
39. Bild DE, Detrano R, Peterson D, Guerci A, Liu K, et al. (2005) Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111:1313-1320. (Pubitemid 40389097)
40. Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, et al. (1996) Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. Circulation 94:1175-1192. (Pubitemid 26292883)
41. Atkinson J. (2008) Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences. J Appl Physiol 105:1643-1651.
42. Allison MA, Wright CM. (2005) Age and gender are the strongest clinical correlates of prevalent coronary calcification (R1). Int J Cardiol 98:325-330. (Pubitemid 40431182)
43. Kolovou GD, Bilianou HG. (2008) Influence of aging and menopause on lipids and lipoproteins in women. Angiology 59:54S-57S.
44. Terauchi M. (2011) Bone and calcium metabolism in menopause transition. Clin Calcium 21:1353-1359.
45. Chen NX, Duan D, O'Neill KD, Moe SM. (2006) High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant 21:3435-3442. (Pubitemid 44817092)
46. Olesen P, Nguyen K, Wogensen L, Ledet T, Rasmussen LM. (2007) Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin. Am J Physiol Heart Circ Physiol 292:H1058-1064.
47. Mody N, Parhami F, Sarafian TA, Demer LL. (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31:509-519. (Pubitemid 32728438)
48. Wadwa RP, Kinney GL, Ogden L, Snell-Bergeon JK, Maahs DM, et al. (2006) Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Int J Biochem Cell Biol 38:996-1003. (Pubitemid 43363428)
49. Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM, Boeschoten EW, et al. (2011) Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant 26:1662-1669.
50. Dellegrottaglie S, Saran R, Gillespie B, Zhang X, Chung S, et al. (2006) Prevalence and predictors of cardiovascular calcium in chronic kidney disease (from the Prospective Longitudinal RRI-CKD Study). Am J Cardiol 98:571-576. (Pubitemid 44233449)
51. Harris DC, Yuill E, Chesher DW. (1995) Correcting acidosis in hemodialysis: effect on phosphate clearance and calcification risk. J Am Soc Nephrol 6:1607-1612. (Pubitemid 26183544)
52. Nitta K. (2011) Vascular calcification in patients with chronic kidney disease. Ther Apher Dial 15:513-521.
53. Kakuta T, Tanaka R, Hyodo T, Suzuki H, Kanai G, et al. (2011) Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients. Am J Kidney Dis 57:422-431.
54. Bas A, Lopez I, Perez J, Rodriguez M, Aguilera-Tejero E. (2006) Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 21:484-490.
55. Zarjou A, Jeney V, Arosio P, Poli M, Antal-Szalmás P, et al. (2009) Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J Am Soc Nephrol 20:1254-1263.
56. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, et al. (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305:1119-1127.
57. Srivaths PR, Goldstein SL, Silverstein DM, Krishnamurthy R, BrewerED. (2011) Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol 26:945-951.
58. Civilibal M, Caliskan S, Kurugoglu S, Candan C, Canpolat N, et al. (2009) Progression of coronary calcification in pediatric chronic kidney disease stage 5. Pediatr Nephrol 24:555-563.
59. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, et al. (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10-17.
60. Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, et al. (2008) The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol 19:1092-1105.
61. Son BK, Kozaki K, Iijima K, Eto M, Kojima T, et al. (2006) Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res 98:1024-1031.
62. Kestenbaum B. (2007) Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment. Semin Dial 20:286-294.
63. Kendrick J, Chonchol M. (2011) The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis 58:826-834.
64. Hruska KA, Mathew S, Lund R, Qiu P, Pratt R. (2008) Hyperphosphatemia of chronic kidney disease. Kidney Int 74:148-157. (Pubitemid 351915080)
65. Cannata-Andia JB, Roman-Garcia P, Hruska K. (2011) The connections between vascular calcification and bone health. Nephrol Dial Transplant 26:3429-3436.
66. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, et al. (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943-1951. (Pubitemid 38822076)
67. Coen G, Pierantozzi A, Spizzichino D, Sardella D, Mantella D, et al. (2010) Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients. BMC Nephrol 11:10.
68. Jean G, Bresson E, Lorriaux C, Mayor B, Hurot JM, et al. (2012) Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients. Nephron Clin Pract 120:c132-138.
69. Neves KR, Graciolli FG, dos Reis LM, Graciolli RG, Neves CL, et al. (2007) Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int 71:1262-1270. (Pubitemid 46884255)
70. Tomson C. (2003) Vascular calcification in chronic renal failure. Nephron Clin Pract 93:c124-130.
71. Barreto FC, Barreto DV, Moyses RM, Neves KR, Canziani ME, et al. (2008) K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 73:771-777. (Pubitemid 351323258)
72. Nasrallah MM, El-Shehaby AR, Salem MM, Osman NA, El Sheikh E, et al. (2010) Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant 25:2679-2685.
73. Inaba M, Okuno S, Imanishi Y, Yamada S, Shioi A, et al. (2006) Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporos Int 17:1506-1513. (Pubitemid 44387485)
74. Masai H, Joki N, Sugi K, Moroi M. (2013) A preliminary study of the potential role of FGF-23 in coronary calcification in patients with suspected coronary artery disease. Atherosclerosis 226:228-233.
75. Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, et al. (2012) FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int 23:2017-2025.
76. Hu MC, Shi M, Zhang J, Quinones H, Griffith C, et al. (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22:124-136.
77. Lim K, Lu TS, Molostvov G, Lee C, Lam FT, et al. (2012) Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 125:2243-2255.
78. Zoppellaro G, Faggin E, Puato M, Pauletto P, Rattazzi M. (2012) Fibroblast growth factor 23 and the bone-vascular axis: lessons learned from animal studies. Am J Kidney Dis 59:135-144.
79. Hruska KA, Mathew S, Saab G. (2005) Bone morphogenetic proteins in vascular calcification. Circ Res 97:105-114. (Pubitemid 41033466)
80. Vliegenthart R, Oei HH, van den Elzen AP, van Rooij FJ, Hofman A, et al. (2004) Alcohol consumption and coronary calcification in a general population. Arch Intern Med 164:2355-2360. (Pubitemid 39532247)